Ratnakar Securities Pvt. Ltd.

OXYGENTA PHARMACEUTICAL LTD.

NSE : NABSE : 524636ISIN CODE : INE102E01018Industry : Pharmaceuticals & DrugsHouse : Private

BSE101.10-4.7 (-4.44 %)

PREV CLOSE ( ) 105.80

OPEN PRICE ( ) 100.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1087

TODAY'S LOW / HIGH ( )100.60 107.95

52 WK LOW / HIGH ( ) 31.01133.5

Quarters

Select year

( in Million)

Particulars

Mar 2025

Dec 2024

Sep 2024

Jun 2024

Audited / UnAudited

UnAudited

Net Sales

494.67

332.06

147.54

126.21

Total Expenditure

511.5

375.63

161.78

144.04

PBIDT (Excl OI)

-16.83

-43.57

-14.24

-17.83

Other Income

0.49

4.88

0.22

Operating Profit

-16.34

-38.69

-14.23

-17.61

Interest

21.28

3.88

6.91

4.07

Exceptional Items

-2.7

PBDT

-40.32

-42.57

-21.14

-21.68

Depreciation

-2.34

7.06

6.6

6.49

Profit Before Tax

-37.98

-49.63

-27.74

-28.17

Tax

-16.46

-10.34

0.81

-14.54

Provisions and contingencies

Profit After Tax

-21.52

-39.29

-28.55

-13.63

Extraordinary Items

Prior Period Expenses

Other Adjustments

0.00

Net Profit

-21.52

-39.29

-28.55

-13.63

Equity Capital

369.84

354.84

Face Value (IN RS)

Reserves

Calculated EPS

-0.58

-1.06

-0.80

-0.38

Calculated EPS (Annualised)

-2.32

-4.24

-3.21

-1.53

No of Public Share Holdings

18077298

16577298

23530200

% of Public Share Holdings

48.88

46.72

66.31

PBIDTM% (Excl OI)

-3.40

-13.12

-9.65

-14.12

PBIDTM%

-3.30

-11.65

-9.64

-13.95

PBDTM%

-8.15

-12.81

-14.32

-17.17

PBTM%

-7.67

-14.94

-18.80

-22.31

PATM%

-4.35

-11.83

-19.35

-10.79

Notes

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Quarterly Results

OXYGENTA PHARMACEUTICAL LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES